Overview
Target therapy is a type of cancer treatment that focuses on specific genetic or molecular changes that are responsible for the growth and spread of cancer. It uses drugs which specifically recognize and bind to these molecular targets and inhibit the growth and spread of cancer cells. Target therapy is particularly effective for stomach cancers, especially those driven by mutations in the HER2 gene, as it can specifically target this type of cancer. Target therapy is a valuable tool in the treatment of stomach cancer as it can improve patient outcomes and reduce the side effects associated with other treatments, such as chemotherapy. Additionally, it can be used alongside other treatments, including surgery and radiotherapy, to provide a more comprehensive approach to the treatment of the cancer.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Adenosquamous Cell Carcinoma of the Stomach 18F-FDG PET/CT Diagnosis and Review of Literature
Capsaicin: A Potential Therapy Adjuvant for Intestinal Bowel Disease
Measuring Quality Change in the Market for Anti-Ulcer Drugs
How this research is being cited
The 4 articles above have been cited 11 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Sherly Usman et al. · 2024 · Berkala Kedokteran
-
2023 · Current Issues in Molecular Biology
-
2023 · Life
-
2023 · Springer eBooks
-
G. I. Robinson et al. · 2023 · Life
-
G. I. Robinson et al. · 2023 · Current Issues in Molecular Biology
-
2022 · Microorganisms
-
A. Shehata et al. · 2022 · Microorganisms
A sample of recent works citing this journal's research on Target Therapy Stomach Cancer, linking to each citing work.